Product Information

Sancuso®  is a skin patch that slowly releases the medicine contained in the adhesive (glue), through clean and intact skin areas into the bloodstream while wearing the patch.
Name Sancuso®
Description Sancuso® (Granisetron Transdermal System) is the first and only FDA-approved patch for the prevention of Chemotherapy Induced Nausea and Vomiting (CINV)
Active substance Granisetron
Indication A serotonin subtype 3 (5-HT3) receptor antagonist indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy for up to 5 consecutive days.
Strengths 34.3mg (3.1mg/24 hours)
Regulatory Status

Approved by United States Food and Drug Administration (FDA) in September 2008., Inserts Code #3001566., Revision date 08/08.

Registered in KSA, Bahrain, Kuwait, Oman, Qatar, UAE, Lebanon and Tunisia

Under registration in Egypt, Algeria and Morocco.

Business Partner Kyowa Hakko Kirin Co. Ltd.